Experimental chemotherapy and radiotherapy to paratesticular rhabdomyosarcoma

J Urol. 1989 Jan;141(1):187-9. doi: 10.1016/s0022-5347(17)40638-0.

Abstract

Experimental chemotherapy and radiotherapy were tried in transplanted tumors derived from a paratesticular embryonal rhabdomyosarcoma. There was no significant difference on the therapeutic effect between a combination chemotherapy composed of vincristine, actinomycin D and cyclophosphamide, so-called "VAC" regimen, and a single therapy of radiation. However, morphologic analyses suggest that VAC is effective in embryonal rhabdomyosarcomas in which undifferentiated rhabdomyoblasts predominate, while radiotherapy is preferable for those containing variously differentiated rhabdomyoblasts.

MeSH terms

  • Adolescent
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cobalt Radioisotopes / therapeutic use
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Dactinomycin / administration & dosage
  • Genital Neoplasms, Male / therapy*
  • Humans
  • Male
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Rabbits
  • Radioisotope Teletherapy
  • Rhabdomyosarcoma / therapy*
  • Spermatic Cord*
  • Vincristine / administration & dosage

Substances

  • Cobalt Radioisotopes
  • Dactinomycin
  • Vincristine
  • Cyclophosphamide

Supplementary concepts

  • VAC protocol